Faes Farma, S.A.

€4.88As of Sun 8 Nov 2026, 12:00 UTC
BME:FAEHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR 7.53%
Div yield 2.62%
ROE 11.22%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.30
PE TTM 19.00
TSR TTM 11.95%
Mkt cap €1.521B
ROIC 8.21%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€5.88
20.29%
(65.51%)
Hold 11|0|3|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.06
0.06
0.06
0.07
13.46%
10.87%
15.22%
17.49%
Revenue€M
131.8
138.7
139.3
144.1
3.22%
7.28%
5.10%
9.91%
Peers (US$1.708B)
Cap (US$)
PE
2.744B
40.61x
1.713B
90.31x
Capital
TTM
5Y
10Y
Leveragex
0.749
0.416
0.421
EBIT/Intx
1.041
0.597
0.602
Own earn%
6.35
163.79
102.73
Sh yield%
28.24
16.15
16.36
Owners
Insiders/Inst%
9.17
80.91
Short interest%
5.61
SBC / revenue%
2.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
14–20
$1 testx
—
Incr. ROIC%
3